UPDATE: Goldman Sachs Downgrades Walgreen Company to Buy, Raises PT on Moderate Upside, ABC Deal

Loading...
Loading...
In a report published Wednesday, Goldman Sachs analyst Matthew J. Fassler downgraded the rating on Walgreen Company
WAG
from Conviction List Buy to Buy, but raised the price target from $46.00 to $50.00. In the report, Fassler noted, “We remove WAG from the Conviction List as we now see moderate (12%) upside to our new $50, 12-month price target, and believe that after WAG's innovative deal with ABC, the market now increasingly appreciates that WAG's association with Alliance-Boots would yield improved strategic corporate direction. We maintain a Buy rating given accelerating earnings momentum and the potential for the ABC distribution deal to drive synergies beyond our current forecast. Since adding WAG to the Conviction List on 9/25/2012, the stock is + 24.0%, vs. the S&P 500 +7.4%. Over the past 12 months, the stock is + 31.4% vs. the S&P 500 +9.8%.” Walgreen Company closed on Tuesday at $44.74.
Posted In: Analyst ColorDowngradesAnalyst RatingsGoldman Sachs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...